Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Am Vet Med Assoc ; 256(8): 914-920, 2020 Apr 15.
Article in English | MEDLINE | ID: mdl-32223709

ABSTRACT

OBJECTIVE: To determine long-term outcomes and factors associated with those outcomes in dogs with gastroesophageal intussusception (GEI). ANIMALS: 36 dogs with GEI evaluated at 16 veterinary hospitals from January 2000 through January 2018. PROCEDURES: Medical records of included dogs were reviewed to collect information regarding signalment, clinical signs, physical examination findings, blood work and diagnostic imaging results, surgical findings, and outcome. Factors were evaluated for associations with various outcomes. RESULTS: Median age of dogs with GEI was 13.2 months, and males (72% [26/36]) and German Shepherd Dogs (33% [12/36]) were most common. Vomiting (67% [24/36]) and regurgitation (33% [12/36]) were the most common clinical signs. Ten of 36 (28%) dogs were euthanized without treatment, and 26 (72%) underwent treatment (25 surgically and 1 endoscopically). Twenty-three of the 26 (88%) treated dogs survived to discharge; median survival time was 995 days. At last follow-up, 15 of the 23 (65%) surviving dogs remained alive and 8 (35%) had died for reasons related to persistent regurgitation (n = 6) or reasons unrelated to GEI (2). Of the 10 dogs for which owners were contacted, 7 had persistent regurgitation, the severity of which was reduced through managed feedings. Dogs with acute (≤ 7 days) clinical signs or a previous diagnosis of megaesophagus were more likely to have persistent regurgitation than were dogs without these factors. CONCLUSIONS AND CLINICAL RELEVANCE: Treatment should be considered for dogs with GEI given the high rate of survival to discharge and median survival time. Although persistent regurgitation was common after treatment, a satisfactory outcome was possible with medical management, including managed feedings and medications.


Subject(s)
Dog Diseases , Esophageal Achalasia/veterinary , Esophageal Diseases/veterinary , Intussusception/veterinary , Stomach Diseases/veterinary , Animals , Dogs , Male , Retrospective Studies , Treatment Outcome
2.
Vet Surg ; 42(5): 535-43, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23650869

ABSTRACT

OBJECTIVE: To evaluate the effect of screw insertion torque on the mechanical properties of four 3.5 mm locking systems: New Generation Devices (NGD), Securos (PAX), Synthes (SYN), and Veterinary Orthopedic Implants (VOI). STUDY DESIGN: In vitro mechanical study. METHODS: Screws were inserted at 1.5 Nm, 2.5 Nm, and 3.5 Nm torques, using dedicated drill guides and a calibrated torque screwdriver. Locking mechanisms were tested under shear loading conditions using a custom-design probe. Tests were conducted under displacement control until failure. Load to failure and interface stiffness were compared between and within groups using a two-factor ANOVA (P < .05). Failure modes were described. RESULTS: The SYN group had significantly greater mechanical properties compared to all other groups at any given insertion torque. Insertion torque had a significant effect on the PAX group, increasing the load to failure by 126% when increasing the insertion torque from 1.5 Nm to 3.5 Nm. Insertion torque had no significant effect on the mechanical properties of the VOI group and limited effect on the NGD and SYN groups. Single failure mode, by screw head decoupling or screw shaft fracture, occurred in the SYN and VOI groups, respectively. In contrast, NGD and PAX systems failed through a combination of screw decoupling and/or bending. CONCLUSIONS: Regardless of insertion torque, the SYN locking mechanism showed the highest failure loads, interfacial stiffness as well as consistent failure mode. These findings highlight the dependability of this system. When using the PAX system an insertion torque of at least 2.5 Nm should be recommended.


Subject(s)
Bone Screws/veterinary , Materials Testing/veterinary , Torque , Animals , Equipment Failure Analysis/instrumentation , Equipment Failure Analysis/methods
3.
J Am Vet Med Assoc ; 242(5): 658-62, 2013 Mar 01.
Article in English | MEDLINE | ID: mdl-23402413

ABSTRACT

CASE DESCRIPTION: An 8-year-old 38-kg (84-lb) castrated male German Shepherd Dog cross was evaluated because of respiratory distress secondary to pneumothorax (detected radio-graphically prior to referral). CLINICAL FINDINGS: CT of the thorax confirmed the presence of pneumothorax and revealed pulmonary blebs without evidence of infiltrative pulmonary changes. A tentative diagnosis of primary spontaneous pneumothorax was made. TREATMENT AND OUTCOME: Exploratory median sternotomy revealed emphysematous changes along the margins of all lung lobes, with the ventral margins of the left cranial, right cranial, and right middle lung lobes most affected. Partial lobectomies of the ventral aspects of these lobes were performed. Histologic examination of tissue samples from the lung lobes revealed diffuse smooth muscle hypertrophy of the terminal and respiratory bronchioles with moderate numbers of peribronchiolar eosinophils. Mucus plugs and mucous cell metaplasia within the airway epithelium were also evident. After surgery, clinical signs resolved and the dog was discharged from the hospital 2 days later. Eight months after surgery, the dog developed a mild cough, and treatment with prednisolone (tapering dosage starting at 0.5 mg/kg [0.023 mg/lb], PO, q 12 h) was initiated. Dosage reduction resulted in recurrence of coughing; however, with continued prednisolone treatment at a dosage of 0.5 mg/kg, PO, once daily, the dog was not coughing at 10 months after surgery. CLINICAL RELEVANCE: Reactive bronchopneumopathy should be included as a differential diagnosis for spontaneous pneumothorax in dogs.


Subject(s)
Asthma/veterinary , Dog Diseases/etiology , Pneumothorax/veterinary , Animals , Anti-Inflammatory Agents/therapeutic use , Asthma/complications , Asthma/drug therapy , Dog Diseases/pathology , Dogs , Male , Pneumothorax/etiology , Pneumothorax/pathology , Pneumothorax/surgery , Prednisolone/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...